Globus Medical, Inc.

NYSE GMED

Globus Medical, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2024: 1.82%

Globus Medical, Inc. Return on Assets (ROA) is 1.82% for the Trailing 12 Months (TTM) ending September 30, 2024, a -66.01% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Globus Medical, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2023 was 5.36%, a -32.31% change year over year.
Globus Medical, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2022 was 7.91%, a -24.30% change year over year.
Globus Medical, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2021 was 10.45%, a 65.80% change year over year.
Globus Medical, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2020 was 6.30%, a -41.03% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

NYSE: GMED

Globus Medical, Inc.

CEO	Mr. Daniel T. Scavilla
IPO Date	Aug. 3, 2012
Location	United States
Headquarters	2560 General Armistead Avenue
Employees	5,000
Sector	Healthcare
Industries Biotechnology 3D Printing Composite Materials Furniture Medical Instruments Pharmaceuticals Plastics Robotics

Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Key trends

Past 5 years